GRI BIOPAR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4301 USD | +0.02% |
|
-6.50% | -93.58% |
| 04-16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
| 2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Chart calendar GRI BIOPAR
10c7e0872582299c6143b63.Vu3z2ipEzjYozMZzajHwkBFeGlm6ypakRKLOFw6T8Z8.MYefthsSuAFO-PY-U3uc-FY5Lh_9oe_eN836JUzngN072ZSIHC6-bkmPqQ~90ea051d8f9bf38e1c401253fa01a855
Upcoming events on GRI BIOPAR
No events available
Past events on GRI BIOPAR
| 17/01/2023 18:00 | Virtual Investor Companies to Watch Event |
| 14/12/2022 13:30 | Vallon Pharmaceuticals and GRI Bio, Inc Merger Call |
| 28/07/2022 13:00 | Interim 2022 Earnings Release |
| 09/05/2022 21:05 | Q1 2022 Earnings Release |
| 23/03/2022 13:00 | Neuroscience Innovation Forum - Panel |
| 14/02/2022 21:15 | FY 2021 Earnings Release |
| 25/01/2022 14:00 | JTC Team Virtual Investor Top Picks Conference |
| 13/01/2022 | APSARD Conference |
| 10/01/2022 12:00 | H.C. Wainwright BioConnect Conference |
| 18/11/2021 20:00 | Virtual Investor Roundtable Event |
| 15/11/2021 13:30 | H.C. Wainwright Virtual Conference |
| 12/11/2021 13:05 | Q3 2021 Earnings Release |
| 17/10/2021 | American Academy of Child and Adolescent Psychiatry Meeting |
| 18/08/2021 17:30 | Q3 Virtual Investor Summit |
| 10/08/2021 13:05 | Interim 2021 Earnings Release |
| 18/05/2021 21:15 | Interim Virtual Investor Summit |
| 13/05/2021 14:15 | Q1 2021 Earnings Release |
| 29/04/2021 15:30 | Neuroscience Innovation Forum - Panel |
| 29/03/2021 13:05 | FY 2020 Earnings Release |
| 09/03/2021 12:00 | H.C. Wainwright Global Life Science Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,10 | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -9,26 -7,67 -20.8% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -9,30 -7,71 -20.71% |
|
Net income Million USD | Released Forecast Spread | -4,82 | -9,30 -7,71 -20.71% |
|
EPS USD | Released Forecast Spread | -32,1 | -42,6 -35,4 -20.34% |
| Announcement Date | 29/03/21 | 14/02/22 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
|
EBIT Million USD | Released Forecast Spread | -3,09 -1,50 -106.27% | -2,63 -1,90 -38.63% | -1,51 -2,45 38.53% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,10 -1,50 -106.4% | -2,64 -1,90 -38.68% | -1,77 -2,45 27.63% | |
|
Net income Million USD | Released Forecast Spread | -1,26 | -3,10 -1,50 -106.4% | -2,64 -1,90 -38.68% | -1,77 -2,45 27.63% |
|
EPS USD | Released Forecast Spread | -5,40 | -13,8 -6,60 -109.09% | -11,7 -6,60 -77.27% | -6,00 -6,90 13.04% |
| Announcement Date | 12/11/21 | 14/02/22 | 09/05/22 | 28/07/22 |
Past sector events for GRI BIOPAR
- Stock Market
- Equities
- GRI Stock
- Calendar GRI BIOPAR
